Horan Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3
Closed -$426 787
2022
Q4
$426 Buy
3
+2
+200% +$279 ﹤0.01% 723
2022
Q3
$0 Sell
1
-1
-50% -$183 ﹤0.01% 701
2022
Q2
$0 Buy
+2
New +$341 ﹤0.01% 716

Other funds holding LABU

Horan Securities's LABU Position: Q1 2023 in Review

Horan Securities sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 3 shares — an estimated $426 sold.

Horan Securities first reported a position in LABU in Q2 2022 and held it in 3 quarters. The position peaked at $426 in Q4 2022. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Horan Securities reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Horan Securities sold 3 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $426.
  • Horan Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and held it in 3 quarters.
  • Horan Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $426 in Q4 2022.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Horan Securities's 13F filing for Q1 2023, filed 18 Apr 2023.